Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

415 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer patients: a retrospective multicenter study.
Hosoya K, Fujimoto D, Morimoto T, Kumagai T, Tamiya A, Taniguchi Y, Yokoyama T, Ishida T, Matsumoto H, Hirano K, Kominami R, Tomii K, Suzuki H, Hirashima T, Tanaka S, Uchida J, Morita M, Kanazu M, Mori M, Nagata K, Fukuda I, Tamiya M. Hosoya K, et al. Among authors: uchida j. BMC Cancer. 2021 Apr 1;21(1):346. doi: 10.1186/s12885-021-08048-4. BMC Cancer. 2021. PMID: 33794809 Free PMC article.
Synergistic antitumor effect of S-1 and the epidermal growth factor receptor inhibitor gefitinib in non-small cell lung cancer cell lines: role of gefitinib-induced down-regulation of thymidylate synthase.
Okabe T, Okamoto I, Tsukioka S, Uchida J, Iwasa T, Yoshida T, Hatashita E, Yamada Y, Satoh T, Tamura K, Fukuoka M, Nakagawa K. Okabe T, et al. Among authors: uchida j. Mol Cancer Ther. 2008 Mar;7(3):599-606. doi: 10.1158/1535-7163.MCT-07-0567. Mol Cancer Ther. 2008. PMID: 18347146
Subacute transient encephalopathy induced by erlotinib.
Okyuama T, Akazawa Y, Uchida J, Nishino K, Kumagai T, Imamura F. Okyuama T, et al. Among authors: uchida j. Oncol Res. 2011;19(8-9):399-402. doi: 10.3727/096504011x13123323849753. Oncol Res. 2011. PMID: 22329199
Small-cell lung carcinoma with long-term survival: A case report.
Nishino K, Imamura F, Kumagai T, Uchida J, Akazawa Y, Okuyama T, Tomita Y. Nishino K, et al. Among authors: uchida j. Oncol Lett. 2011 Sep 1;2(5):827-830. doi: 10.3892/ol.2011.355. Epub 2011 Jul 5. Oncol Lett. 2011. PMID: 22866135 Free PMC article.
Endotracheal bronchogenic cyst.
Okuyama T, Akazawa Y, Uchida J, Nishino K, Kumagai T, Imamura F. Okuyama T, et al. Among authors: uchida j. J Bronchology Interv Pulmonol. 2011 Oct;18(4):340-2. doi: 10.1097/LBR.0b013e3182310d41. J Bronchology Interv Pulmonol. 2011. PMID: 23208629
Randomized Phase II trial of paclitaxel and carboplatin followed by gemcitabine switch-maintenance therapy versus gemcitabine and carboplatin followed by gemcitabine continuation-maintenance therapy in previously untreated advanced non-small cell lung cancer.
Minami S, Kijima T, Shiroyama T, Okafuji K, Hirashima T, Uchida J, Imamura F, Osaki T, Nakatani T, Ogata Y, Yamamoto S, Namba Y, Otsuka T, Tachibana I, Komuta K, Kawase I. Minami S, et al. Among authors: uchida j. BMC Res Notes. 2013 Jan 3;6:3. doi: 10.1186/1756-0500-6-3. BMC Res Notes. 2013. PMID: 23281805 Free PMC article. Clinical Trial.
415 results